We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Biobank of airway biopsies

A Southampton Clinical Research Facility success story.

Researchers carried out fibreoptic bronchoscopy on healthy volunteers, and volunteers with either asthma or chronic obstructive pulmonary disease (COPD).

This generated a unique biobank of airway biopsies in these three groups of volunteers.

This resource has been used to discover a major defect in innate immunity of asthmatic and COPD epithelial cells: a defect in beta- and lambda-inteferon production makes these cells unable to effectively eliminate the common cold virus (rhinovirus).

This defect explains the increased susceptibility of these patients to virus-induced exacerbations, a major unmet clinical need.

The paper 'Asthmatic Bronchial Epithelial Cells Have a Deficient Innate Immune Response to Infection with Rhinovirus' was published on 21 March 2005 in the 'Journal of Experimental Medicine' (volume 201, no. 6, 937-947).

Find out more about the Southampton Clinical Research Facility.

Share |
Home  >  Funding  >  Biomedical science  >  Funded projects  >  Major initiatives  >  Clinical Research Facilities  > Biobank of airway biopsies
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888